Patent · US Active

Rapid antimicrobial susceptibility testing based on a unique spectral intensity ratio analysis via single fluorescence membrane dye staining and flow cytometry

US10995357B2 · kind B2 · utility

0Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 2018
Grant dateMay 4, 2021
Priority date
Expiry dateFeb 17, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Single dye fluorescent staining and the combination of differences in both intensity and spectral emission permit determination of the minimum concentration of an antibiotic needed to inactivate bacteria (Minimum Inhibitory Concentration (MIC)), thereby providing a means for rapid Antibiotic Susceptibility Testing (AST). This allows for a quick and easy means for clinicians to determine a suitable treatment regimen for patients suffering from bacterial infections and those that eventually lead to sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.